You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PALB2 Gene Mutation

Showing 1 - 25 of 9,119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

Not yet recruiting
  • BRCA Mutation
  • +3 more
  • Tamoxifen 10 Mg Tablet
  • +2 more
  • Genoa, Italy
  • +3 more
Sep 11, 2023

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

The Pancreas Interception Center for Early Detection,

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +12 more
  • Data collection
  • Tampa, Florida
    Moffitt Cancer Center
Jan 11, 2023

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

Recruiting
  • BARD1 Gene Mutation
  • +14 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
  • +1 more
Jun 14, 2022

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

Active, not recruiting
  • Deleterious BARD1 Gene Mutation
  • +13 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Chicago, Illinois
  • +8 more
Feb 25, 2022

Breast Cancer, Advanced Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University
Nov 9, 2022

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

    Not yet recruiting
    • AXIN1 Gene Mutation
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

    Recruiting
    • Metastatic Solid Tumor
    • +4 more
    • Recommendation for treatment with immunotherapy
    • Baltimore, Maryland
      Johns Hopkins University
    Sep 8, 2022

    Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NFS-02 Injection
    • (no location specified)
    Apr 6, 2023

    Leber Congenital Amaurosis Trial in Shanghai (HG004)

    Recruiting
    • Leber Congenital Amaurosis
    • HG004
    • Shanghai, Shanghai, China
      Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
    Oct 12, 2023

    Trial

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NR082 Injection
    • Injection needle
    • (no location specified)
    Jan 30, 2023

    Patients With G2019S LRRK2 Parkinson's Disease

    Suspended
    • Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene
    • Observational
    • Culver City, California
      Science 37
    Aug 15, 2022

    Leber Congenital Amaurosis Trial in Shanghai (HG004)

    Recruiting
    • Leber Congenital Amaurosis
    • HG004
    • Shanghai, Shanghai, China
      Xinhua Hospital affiliated with Shanghai Jiao Tong University Sc
    Sep 26, 2023

    Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

    Recruiting
    • Cancer
    • +6 more
    • Indianapolis, Indiana
      Indiana University Hospital / IU Simon Cancer Center
    Jan 12, 2023

    Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II Trial in Milan (Video capsule endoscopy)

    Recruiting
    • Lynch Syndrome
    • +7 more
    • Video capsule endoscopy
    • Milan, Lombardia, Italy
      San Raffaele Scientific Institute, Gastroenterology and Gastroin
    Jan 27, 2023

    Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • (no location specified)
    Aug 10, 2022